News roundup Friday, May 31

The latest from BioStock

» She is CombiGene's new CSO
» Synartro prepares for clinic
» BioInvent presents promising clinical data at ASCO and EHA
» Abliva's CEO: "We remain on track for the interim analysis early in Q3"
» Alzinova's CEO: "This strengthens our negotiating position towards potential partners"

Read BioStock's weekly newsletter for v.21 here.

BioStock Global Forum

Yesterday was the last day of the two-day event. BioStock Global ForumTo see all the highlights from day 1, click here and here. Highlights from day 2 can be seen here and here.

The latest news of the day

The rights issue of SEK 45,1 million was fully subscribed and the company has decided on a directed issue to guarantors. Read more.

New CFO at Neola Medical ahead of market launch in the USA. Read more.

CLS decides on a partially guaranteed rights issue of approximately SEK 59 million. Read more.

BioInvent invites to a digital KOL event on June 18, 2024 to discuss the recently published efficacy data for its lead candidates BI-1808 and BI-1206. Read more.

24 weeks of dosing have been completed in Stage 1 of Abliva FALCON study with KL1333 in primary mitochondrial disease. Read more.

Ecti Research announces that efficacy studies in an animal model of uveal melanoma show inhibited tumor growth. Read more.

Peptonic Medical Patent granted in Europe for relief of provoked vulvodynia in women. Product ready for launch. Read more.

Calliditas Therapeutics Partner WHAT TO receives positive feedback from CHMP concerning Kinpeygo. Read more.

Toleranzia conducts successful safety study of TOL2 in blood samples from patients with myasthenia gravis. Read more.

Subscription period in NextCells Rights issue begins today. Read more.

NextCell Pharma publishes a prospectus in connection with a rights issue of units of approximately SEK 40,1 million. Read more.

Medivir announces the issuance, repurchase and conversion of C shares and the transfer of common shares within the framework of the LTIP. Read more.

Arcoma launching the next generation Arcoma Intuition i3. Read more.

Dicot has changed its name to Dicot Pharma. Read more.

Magle Group and Amniotic has been merged. Read moreStatement from Amniotic's board of directors. Read more.

Kalqyl has published an updated analysis of Chordate Medical. Read more.

Board member Bert Junno has resigned from Cyxones board. Read more.

Bavarian Nordic and CEPI Collaboration is being entered into to promote mpox vaccination in Africa. Read more.

UsDsign announces that 5000 patients have been treated with UsDsign Catalyst in the United States. Read more.

Fluicell announces the outcome of the exercise of warrants of series TO5. Read more.

Devotion wins procurement for NGS-based oncology products in Italy. Read more.

Ecti Research reduces its cost base. Read more.

AlK-Abellós European registration application for ITULAZAX for pediatric indication has been accepted for review. Read more.

ProstaLund receives subscription commitments corresponding to approximately 34 percent of the upcoming rights issue. Read more.

RaySearch Laboratories announces the release of the latest version of RayCare, the next generation oncology information system. Read more.

Salén Enterprise announces the outcome of the mandatory bid to the shareholders of NeoDynamics. Read more.

AegirBio carries out a previously announced directed new share issue to Atlas Special Opportunities and calls for payment of Tranche 2. Read more.

BioPorto has appointed Niels Hoy Nielsen to new EVP and CFO and member of Group Management from August 1. Read more.

Today, trading begins in SciBase new shares and warrants of series TO 2. Read more.

Alteco Medical prepares a control balance sheet. Read more.

Stenocare updates regarding its pipeline. Read more.

Changes in A3P Biomedicals management. Read more.